For & Against

What's Next

The next 3–6 months are unusually single-event-driven. One earnings print — 1Q26 on 1 June 2026 — resolves most of the active disagreement on this stock. Every other dated item on the calendar is either the venue for that print (AGM, dividend cycle) or peer context for the same demand question.

No Results

What the market watches most closely. The 1 June 1Q26 print is the only event that can resolve the thesis on its own. Consensus for FY26 carries net income of RM 247M ($56M) — roughly flat on FY25's RM 227M — which implicitly requires quarterly runs of RM 55–65M. A print below RM 30M crosses the line both Bull and Bear name as a falsification trigger. A print above RM 45M with matched operating cash flow is the cleanest bull-case confirmation this calendar can deliver. The 2Q26 print in late August is the second, harder test — by then the 2024 forward-sold hedge is fully rolled off and no accounting cushion remains.

An undated but material overhang: the Ivorian regulator's October 2024 dialogue about an additional Transcao stake has not progressed to an announced timeline. Treat it as optionality, not schedule.

For / Against / My View

For

**1. The 2025 cash swing was real, not an accrual.** FY2025 operating cash flow flipped from **−$406M to +$283M** (RM −1.68B → +RM 1.17B) — a ~$690M swing in twelve months — and management used it to repay **$221M of debt (RM 914M)**, cutting debt/equity from 2.03× to 1.43× in a single year. The earnings bears called fictional just monetized to the bank. *Evidence: OCF +RM 1,171M FY25 vs −RM 1,676M FY24; debt repayments RM 914M; D/E 1.43×.*

**2. Structural cost moat is getting wider, not narrower.** Malaysian/Ivorian processing costs run **30–40% below Zurich/Antwerp**, and the tax-free Ivory Coast plant is still ramping. While Barry Callebaut is cutting FY25/26 volumes and burning cash to de-lever from 4.5× EBITDA, GCB is pushing volume into the same softening market with a structurally lower cost base and a 25% Transcao stake adding ~80,000 MT of origin-side access. *Evidence: Malaysian/Ivorian cost base 30–40% below Zurich/Antwerp; Transcao 25% delivered for RM 130M.*

**3. Insiders are buying the low; alignment is extreme.** On **6 April 2026 the CEO bought 200,000 shares at RM 0.710** — weeks from the 52-week low of RM 0.65, and after the FY2025 earnings halving was already in the tape. **~64% of shares are family-controlled**, no director has publicly sold, and a 10% buyback mandate sits unused at 0.88× book. RSI 69, MACD positive, +28% off the February floor. *Evidence: CEO Tay Hoe Lian purchase 200k @ RM 0.710, 6 Apr 2026; family control 64%; no insider sales.*

Bull price target

$0.38

Implied upside

90%

Bull target: $0.38 / RM 1.55 over 12–15 months on 11× normalized EPS of RM 0.14; triggered by Net Debt/EBITDA falling under 4× on continued inventory unwind. Disconfirmed if 4Q25 and 1Q26 both print under RM 30M net income with leverage stuck above 6×.

Against

**1. Forward-selling cushion exhausts in 1H26.** Quarterly net income already stepped from 4Q24's peak of $48M to $10M in both 3Q25 and 4Q25 — an 80% cut while the 2024 forward-sold ratio hedge was still live. When those locked-in contracts roll off in 1H26, the next two prints drop through the RM30M/quarter falsification line and force consensus earnings resets. *Evidence: EBITDA margin compressed from 10.1% (4Q24) to 3.5% (3Q25) while revenue hit records.*

**2. Interest now eats 53% of EBITDA — structurally.** Finance costs rose from $13M (FY22) to $79M (FY25) — a 6× jump over three years — and now consume 53% of EBITDA against 7% in FY20. Interest coverage is 1.87×, Net Debt/EBITDA is 4.87×, and the denominator is still contracting; a further 20% EBITDA erosion pushes leverage through 6× into covenant-sensitive territory. *Evidence: Interest expense went from RM56M (FY2022) to RM336M (FY2025) — a 6× jump.*

**3. 14.3% of total shares pledged inside the promoter block.** Guan Chong Resources owns 49.86% but has **28.6% of its controlling stake — 14.3% of GCB total — in pledged securities accounts** at RHB and AmBank. The stock already touched RM 0.65 on 6 Feb 2026. A further 20% leg lower triggers margin calls into a ~24% free float, liquidating price independent of fundamentals. *Evidence: 92.5M + 74.9M promoter shares pledged at RHB / AmBank; 52-week low RM 0.65 on 6 Feb 2026.*

Bear downside target

$0.14

Implied downside

-33%

Bear target: $0.14 / RM 0.58 over 12–18 months, anchored to adjusted book after a 15% inventory haircut; triggered by 1H26 prints under RM 30M or a material FY25 audit inventory write-down.

The Tensions

1. Is 0.88× book a dislocation, or does it hide a peak-cocoa markup?

Bull says book equity already survived the FY25 cocoa-price collapse and still printed +RM 884M FCF and RM 227M net income, so the 15-year-trough P/B reads as a dislocation. Bear says FY2024 bean inventory ballooned to RM 5.5B at near-peak prices and London front-month has since fallen ~45% — a RM 800M–1.5B inventory haircut collapses book/share from RM 0.83 toward RM 0.54, making today's 0.88× actually ~1.3× on adjusted book. Both cite the same FY2024 bean inventory at RM 5.5B and the same ~45% bean-price decline. This resolves on the FY25 audited annual report and any interim inventory-mark review disclosed before the 1 June 1Q26 print — if there is no material write-down and book/share holds near RM 0.83, Bull wins; if auditors force even a 10% mark, Bear wins mechanically.

2. Is the cash swing a regime change, or one-off inventory liquidation?

Bull reads the +RM 2.85B OCF swing and RM 914M debt repayment in FY25 as earnings becoming real cash and the start of a de-leveraging cycle. Bear reads the same cash as one-off inventory monetization at falling prices, pointing to the five-year cumulative proof: net income +RM 1,059M against operating cash flow −RM 1,042M. Both cite the same FY25 cash delivery and the same 5-year OCF/NI gap. This resolves on the OCF disclosure in the 1 June 1Q26 print — if 1Q26 OCF is positive and roughly tracks reported net income without further inventory drawdown, Bull's regime change is live; if OCF prints negative or is visibly funded by continued inventory liquidation at lower prices, Bear's run-off reading is confirmed.

3. Is the controlling family aligned or a loaded spring?

Bull points to the 64% family-controlled cap table, the CEO's 6 April 2026 buy at RM 0.710, and zero director sales as extreme alignment at the low. Bear points to the same family block and notes 14.3% of total shares are pledged inside Guan Chong Resources at RHB and AmBank — alignment in fair weather, forced-seller in a drawdown. Both cite the same 49.86% GCR block and the same promoter register. This resolves on whether the share price holds above RM 0.65 through the 1 June print — a print that clears RM 30M releases the pledge overhang by default; a miss breaks the RM 0.65 floor and the pledged shares become the marginal seller.

My View

I'd lean cautious here — slight edge to the Against side. The three tensions all resolve on the same datapoint (the 1 June 1Q26 print), and two of them (cash-swing regime change, pledged-share mechanics) only pay off if earnings clear the RM 30M bar that both sides named as the falsification line. Consensus needs quarterly runs of RM 55–65M to hit the FY26 number, and the 2024 forward-sold hedge — the one accounting cushion keeping the last four quarters off zero — rolls off precisely now. That's an asymmetric setup against the bull, even with a structurally cheap book and an aligned founder. The view flips to cautiously constructive if 1Q26 prints above RM 40M net income with positive operating cash flow that tracks it — that single datapoint neutralizes the forward-sold objection, defuses the pledge overhang, and lets the 0.88× P/B argue for itself. Until then, the cost to wait six weeks for the print is small, and the cost to be wrong is mechanical.